“…Many of the triggers associated with type 1 diabetes, such as inflammatory cytokines, free radicals, and viral infections, result in endoplasmic reticulum (ER) or oxidative stress (3)(4)(5)(6)(7)(8)(9)(10)(11). These stresses can lead to modifications of b-cell proteins, including posttranslational modifications (PTMs) (10,(12)(13)(14)(15)(16)(17), mRNA alternative splicing, hybrid peptide formation (18,19), and nonconventional translation, potentially generating neoepitopes against which no tolerance exists in the immune system (20). In several autoimmune diseases, such as rheumatoid arthritis, multiple sclerosis, systemic lupus erythematosus, and celiac disease, PTM proteins are established autoantigens (21,22), but their relevance in type 1 diabetes is only starting to be explored.…”